Metraipolis › archive › dc_22c674fa9e10

Berberine signature and cardiometabolic diseases using randomized controlled trial, cohort study and Mendelian randomization — Europe PMC PMID:41882153

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41882153
DOI
10.1038/s44325-[numero omesso]-w
License (as archived)
solo-consultazione
Archived
2026-11-03T23:20:01.029Z
SHA-256 of the archived text
0e114b10ed75e5ad302b0443d735f2f7338d18bc358f88d3b5170c2ea1df8a49
Stable URL of this page
https://metraipolis.com/documento/dc_22c674fa9e10

How to cite

Berberine signature and cardiometabolic diseases using randomized controlled trial, cohort study and Mendelian randomization — Europe PMC PMID:41882153 — Europe PMC (en), https://europepmc.org/article/MED/41882153 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_22c674fa9e10 (Metraipolis archive dc_22c674fa9e10, sha256 0e114b10ed75e5ad302b0443d735f2f7338d18bc358f88d3b5170c2ea1df8a49)
BibTeX
@misc{dc22c674fa9e10,
  title = {Berberine signature and cardiometabolic diseases using randomized controlled trial, cohort study and Mendelian randomization — Europe PMC PMID:41882153},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41882153},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_22c674fa9e10; sha256 0e114b10ed75e5ad302b0443d735f2f7338d18bc358f88d3b5170c2ea1df8a49},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41882153. Agents can read the archived copy with the MCP tool read_document.